Egbert Smit
Overview
Explore the profile of Egbert Smit including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
2933
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ruiter J, de Langen A, Monkhorst K, Veenhof A, Klomp H, Smit J, et al.
Acta Chir Belg
. 2024 Feb;
124(5):387-395.
PMID: 38404182
Background: Previous studies investigating whether metastatic lymph node count is a relevant prognostic factor in pathological N1 non-small cell lung cancer (NSCLC), showed conflicting results. Hypothesizing that outcome may also...
2.
Miedema I, Wijngaarden J, Pouw J, Zwezerijnen G, Sebus H, Smit E, et al.
Cancers (Basel)
. 2023 Dec;
15(23).
PMID: 38067257
Introduction: Zr-immuno-PET (positron emission tomography with zirconium-89-labeled monoclonal antibodies ([Zr]Zr-mAbs)) can be used to study the biodistribution of mAbs targeting the immune system. The measured uptake consists of target-specific and...
3.
Yu H, Goto Y, Hayashi H, Felip E, Yang J, Reck M, et al.
J Clin Oncol
. 2023 Sep;
41(35):5363-5375.
PMID: 37689979
Purpose: Patritumab deruxtecan, or HER3-DXd, is an antibody-drug conjugate consisting of a fully human monoclonal antibody to human epidermal growth factor receptor 3 (HER3) attached to a topoisomerase I inhibitor...
4.
Tohidinezhad F, Bontempi D, Zhang Z, Dingemans A, Aerts J, Bootsma G, et al.
Eur J Cancer
. 2023 Mar;
183:142-151.
PMID: 36857819
Introduction: Immunotherapy-induced pneumonitis (IIP) is a serious side-effect which requires accurate diagnosis and management with high-dose corticosteroids. The differential diagnosis between IIP and other types of pneumonitis (OTP) remains challenging...
5.
Fukuoka M, Yano S, Giaccone G, Tamura T, Nakagawa K, Douillard J, et al.
J Clin Oncol
. 2023 Feb;
41(6):1162-1171.
PMID: 36791474
Purpose: To evaluate the efficacy and tolerability of two doses of gefitinib (Iressa [ZD1839]; AstraZeneca, Wilmington, DE), a novel epidermal growth factor receptor tyrosine kinase inhibitor, in patients with pretreated...
6.
Camidge D, Moran T, Demedts I, Grosch H, Mileham K, Molina J, et al.
Clin Lung Cancer
. 2022 Apr;
23(4):300-310.
PMID: 35400584
Introduction: The hepatocyte growth factor receptor MET represents a resistance mechanism to epidermal growth factor receptor (EGFR) inhibition in EGFR mutant (mt) non-small cell lung cancer (NSCLC). This Phase 2...
7.
Cortot A, Le X, Smit E, Viteri S, Kato T, Sakai H, et al.
Clin Lung Cancer
. 2022 Mar;
23(3):195-207.
PMID: 35272955
MET exon 14 (METex14) skipping mutations occur in 3% to 4% of non-small cell lung cancer (NSCLC) cases. Currently, four oral MET tyrosine kinase inhibitors (TKIs) are in use for...
8.
van de Ven M, Koffijberg H, Retel V, Monkhorst K, Smit E, van Harten W, et al.
J Mol Diagn
. 2021 Jan;
23(4):484-494.
PMID: 33493663
The continued introduction of biomarkers and innovative testing methods makes already complex diagnosis in patients with stage IV non-small-cell lung cancer (NSCLC) even more complex. This study primarily analyzed variations...
9.
De Ruysscher D, Dingemans A, Praag J, Belderbos J, Tissing-Tan C, Herder J, et al.
J Clin Oncol
. 2018 May;
36(23):2366-2377.
PMID: 29787357
Purpose The purpose of the current study was to investigate whether prophylactic cranial irradiation (PCI) reduces the incidence of symptomatic brain metastases in patients with stage III non-small-cell lung cancer...
10.
Manegold C, Adjei A, Bussolino F, Cappuzzo F, Crino L, Dziadziuszko R, et al.
ESMO Open
. 2018 Feb;
1(6):e000118.
PMID: 29435365
Despite the efficacy of a number of first-line treatments, most patients with advanced-stage non-small cell lung cancer (NSCLC) experience disease progression that warrants further treatment. In this review, we examine...